Overview

Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction

Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nicorandil reduce cardiac infarct size in patient with ST-segment elevation acute myocardial infarction.
Phase:
Phase 3
Details
Lead Sponsor:
Pusan National University Hospital
Collaborator:
JW Pharmaceutical
Treatments:
Nicorandil